Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Coloplast A/S
  6. News
  7. Summary
    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 12/03 10:59:46 am
1053.5 DKK   -1.22%
12/03COLOPLAST A/S : Ex-dividend day for final dividend
FA
12/02COLOPLAST A/S : Voting results
PU
12/02Coloplast A/S - Announcement no. 11/2021 - Decisions at the Annual General Meeting 2021
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coloplast A/S : - Announcement no. 05/2021 - Financial Calendar 2021-22

08/26/2021 | 08:06am EST

Please see enclosed pdf.

For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/.

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

 

For further information, please contact
  
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376
Email: dkebj@coloplast.com

Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com                                                                       

Press and the media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com


This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-08.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment

  • 05_2021_Financial Calendar 2021-22

© OMX, source GlobeNewswire - EU Press Releases

All news about COLOPLAST A/S
12/03COLOPLAST A/S : Ex-dividend day for final dividend
FA
12/02COLOPLAST A/S : Voting results
PU
12/02Coloplast A/S - Announcement no. 11/2021 - Decisions at the Annual General Meeting 2021
AQ
12/02Coloplast A/S Elects Annette Br?ls as Member of the Board of Directors
CI
11/09Coloplast A/S - Announcement no. 10/2021 - Notice of Annual General Meeting
AQ
11/08GLOBAL MARKETS LIVE : Qiagen, Alcon, Boeing, Berkshire Hathaway...
11/08Coloplast to acquire Atos Medical in $2.5 billion deal, shares rise
RE
11/08Coloplast A/S - Announcement no. 09/2021 - Coloplast announces agreement to acquire Ato..
AQ
11/08COLOPLAST A/S (CPSE : COLO B) signed an agreement to acquire Atos Medical AB from PAI Euro..
CI
11/01Coloplast A/S Reports Earnings Results for the Full Year Ended September 30, 2021
CI
More news
Analyst Recommendations on COLOPLAST A/S
More recommendations
Financials
Sales 2022 21 205 M 3 227 M 3 227 M
Net income 2022 5 109 M 778 M 778 M
Net Debt 2022 2 051 M 312 M 312 M
P/E ratio 2022 43,8x
Yield 2022 1,84%
Capitalization 224 B 34 057 M 34 121 M
EV / Sales 2022 10,7x
EV / Sales 2023 9,80x
Nbr of Employees 12 728
Free-Float 57,4%
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | MarketScreener
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 1 053,50 DKK
Average target price 1 075,81 DKK
Spread / Average Target 2,12%
EPS Revisions
Managers and Directors
Kristian Villumsen President & Chief Executive Officer
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Lars S°ren Rasmussen Chairman
Oliver Johansen Senior VP-Global Research & Development
Allan Rasmussen Executive Vice President-Global Operations